1Simpkin JW, Green PS, Gridley KE, et al. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am J Med,1997,103:19-25.
2Waring SC, Rocca WA, Petersen RC, et al. Post menopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology,1999,52:965-970.
3Zhang ZX, Zhao JH, Huang JB, et al. ′99 International Symposium on Aging and Antiaging Science & Technology,1999,September,p2.
4Baldereschi M, Di Carlo A, Lepore V, et al. Estroge replacement therapy and Alzheimer's disease in the longitudinal study on aging. Neurology,1998,50:996-1002.
5Yaffe K, Sawaya G, Lieberburg I, et al. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA,1998,279:688-695.
6Slooter AJ, Bronzova J, Witteman JC, et al. Estrogen use and early onset Alzheimer's disease. J NeurosurgPsychiatry,1999,67:779-781.
7Kawas C, Resnich S, Morruson A, et al. A prospective Alzheimer's disease. The Baltimore longitudenal study of aging. Neurology,1997,48:1517-1521.
8Brenner DE. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease:a population-based case-control study.Am J Epidemiol,1994,140:262-267.
9Gould E. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci,1990,10:1286-1291.
10McEwen BS. Ovarian steroids and the brain:implications for condition and aging. Neurology,1997,48:8-15.
